Hester Biosciences has informed that as per Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended time to time), a Meeting of the Board of Directors of the Company will be held on Wednesday, 29 April 2020 at 9.30 am, to consider and approve the change of Chief Financial Officer (Key Managerial Personnel) of the Company.
The above information is a part of company’s filings submitted to BSE.